These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET. Leyton J, Iddon L, Perumal M, Indrevoll B, Glaser M, Robins E, George AJ, Cuthbertson A, Luthra SK, Aboagye EO. J Nucl Med; 2011 Sep; 52(9):1441-8. PubMed ID: 21852355 [Abstract] [Full Text] [Related]
3. Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide. Meisetschläger G, Poethko T, Stahl A, Wolf I, Scheidhauer K, Schottelius M, Herz M, Wester HJ, Schwaiger M. J Nucl Med; 2006 Apr; 47(4):566-73. PubMed ID: 16595488 [Abstract] [Full Text] [Related]
5. Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. Iddon L, Leyton J, Indrevoll B, Glaser M, Robins EG, George AJ, Cuthbertson A, Luthra SK, Aboagye EO. Bioorg Med Chem Lett; 2011 May 15; 21(10):3122-7. PubMed ID: 21458258 [Abstract] [Full Text] [Related]
8. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. Clin Cancer Res; 2004 Jun 01; 10(11):3593-606. PubMed ID: 15173065 [Abstract] [Full Text] [Related]
9. Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors. Dubash SR, Keat N, Mapelli P, Twyman F, Carroll L, Kozlowski K, Al-Nahhas A, Saleem A, Huiban M, Janisch R, Frilling A, Sharma R, Aboagye EO. J Nucl Med; 2016 Aug 01; 57(8):1207-13. PubMed ID: 27173162 [Abstract] [Full Text] [Related]
16. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Wester HJ, Schottelius M, Scheidhauer K, Meisetschläger G, Herz M, Rau FC, Reubi JC, Schwaiger M. Eur J Nucl Med Mol Imaging; 2003 Jan 01; 30(1):117-22. PubMed ID: 12483418 [Abstract] [Full Text] [Related]
20. Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro. Capello A, Krenning EP, Breeman WA, Bernard BF, Konijnenberg MW, de Jong M. Cancer Biother Radiopharm; 2003 Oct 01; 18(5):761-8. PubMed ID: 14629824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]